Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Asarum sieboldii* (Miq.), commonly known as Xi Xin in traditional Chinese medicine, is a medicinal herb native to East Asia. It is primarily valued for its essential oils and ethanol extracts, which contain bioactive compounds such as methyleugenol, asarinin, and higenamine. The herb is traditionally used to treat respiratory conditions like asthma, allergic rhinitis, and sinusitis, as well as for pain relief (analgesia) and dental health. Pharmacological studies indicate it possesses anti-inflammatory, antiallergic, and analgesic properties, mediated through mechanisms such as the inhibition of Th2-mediated immune responses, modulation of TRPV4 channels, and regulation of tight junction proteins. While effective, its use requires caution due to the presence of aristolochic acids, which are known nephrotoxins and carcinogens, although *A. sieboldii* typically contains lower levels compared to other *Asarum* species.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on asarum sieboldii.